MW2022-06-22 - A multicenter prospective randomized double blind placebo controlled adaptive design study performed to evaluate the efficacy and the safety of EscharEx in debridement of Venous Leg Ulcers (VALUE)

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

Conditions:
Venous Leg Ulcers
Age: Between 18 Year(s) - 100 Year(s)
Gender: Male or Female

Other Inclusion Criteria:
1. Men or women, older than 18 years of age
2. Patients with a venous leg ulcer
3. Patients understand the nature of the procedure, are able to adhere to the protocol regimen, and provide a written informed consent prior to any study procedure

You may not be eligible for this study if the following are true:

1. Presence of gangrene, signs of systemic infection, sepsis, or osteomyelitis
2. Patients with skin disorders unrelated to the wound that are present adjacent to the wound
3. Patients with primary lymphatic edema (lymphedema)
4. Patients undergoing renal or peritoneal dialysis
5. Concurrent use of non-approved drugs or alcohol abuse
6. Pregnant women (positive pregnancy test) or nursing mothers

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies